Medacta Group Sa · SIX:MOVE
Medacta Group Sa — FY2019 Earnings Presentation
10 slides from Medacta Group Sa's earnings presentation, Jan 21, 2020
Slide 1: FY 2019 Financial results
FY 2019 Financial results Preliminary unaudited top-line figures 21st January 2020 PATIENT WELL-BEING MEDICAL EDUCATION INNOVATION 1
Slide 2: Disclaimer
Disclaimer This presentation (the "Presentation") has been prepared by Medacta Group SA ("Medacta" and together with its subsidiaries, "we", "us" or the "Group"). The information contained in the Presentation does not purport to be comprehensive. Please refer to the financial reports available on ou
Slide 3: Agenda
Agenda FY 2019 Unaudited Revenue 3
Slide 4: Medacta confirms strong revenue growth, significantly above market
Medacta confirms strong revenue growth, significantly above market (Unaudited figures) Significant growth above the market Organic growth of 14.0% and revenue up to €310.9 million, equal to +11.4% in CC1 (positive FX effect mainly from USD) Positive contribution from all business lines: • Good and s
Slide 5: FY'18-19: Revenue bridge by Product and region
FY’18-19: Revenue bridge by Product and region (Unaudited) Revenue Bridge by Product Commentary 5.3% 13.3% 147.3% 23.4% 11.4% 14.0% 6.7% 20.5% 302.9% 37.1% 14.3% 11.4% Stable growth rate in Hip, slight 7.2 310.9 12.7 5.6 4.6 303.7 3.0 5.4 279.8 (7.2) 8.1 reduction due to physiological 16.8 272.6 9.9
Slide 6: FY'19: Revenue up by 14.0% to €310.9 million - growth by products
FY’19: Revenue up by 14.0% to €310.9 million (+11.4% in CC) Sales growth in all business lines... (Unaudited) Growth by products (%)1 Commentary Strong organic growth in all business lines above market Hip 5.3% Steady growth in the core Hip business sustained by AMIS technique Knee 13.3% Very good c
Slide 7: 1H – 2H - Sales Growth Comparison by products
1H – 2H - Sales Growth Comparison by products (Unaudited) 1H Growth by products (%)1 2H Growth by products (%)1 Commentary Growth rate in 2H higher than 1H Hip 6.4% Hip 4.2% Hip business slow down in 2H due to delays in getting some anticipated new customers on board Knee 13.5% Knee 13.0% Knee growt
Slide 8: FY'19: Revenue up by 14.0% - growth in all regions
FY’19: Revenue up by 14.0% to €310.9 million (+11.4% in CC) ...and in all regions (Unaudited) Growth by regions (%)1 Commentary Well balanced growth in all geographies Europe 8.0% Europe, good performance above the market despite price pressure in some countries (France and Belgium) NA 13.2% NA, ove
Slide 9: 1H – 2H - Sales Growth Comparison by geographies
1H – 2H - Sales Growth Comparison by geographies (Unaudited) 1H Growth by regions (%)1 2H Growth by regions (%)1 Commentary Good and stable growth rate in Europe Despite price cuts in France and Belgium Europe 8.2% Europe 7.7% NA, positive results in 2H slightly below expectations due to some delays
Slide 10: THANK YOU!
THANK YOU! 10